chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 34-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.    Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Non-significant follow-up received on 28 Sep 2021
Returned to clinic 2 days later with erythema, induration, swelling at site 12 cm x 9 cm.
Information has been received from a registered nurse (RN) concerning a female co-worker who, while administering the first SC 0.5 mL dose of Varivax (Lot #652555/1023R) in the right thigh to a patient on 21-FEB-2006 at 1100, was splashed in the eye with the vaccine due to a loose needle hub on the syringe. Unspecified medical attention was sought, but no adverse experience was related to the incident. Follow-up information received from the 25-year-old black female with no medical history indicated that immediately after being splashed in the eye with the vaccine she experienced eye irritation. An eye examination was negative. Additional information is not expected.
fever; nausea; chills; headache; This is a spontaneous report from a contactable consumer (patient) via self reporting system. A 24-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 14Mar2021 16:00 (lot number: EN6208; expiry date: unknown) at the age of 24-years-old, as dose 1, single for Covid-19 immunisation. The patient had no relevant medical history. The patient was not diagnosed with Covid-19 prior vaccination. The patient had no known allergies. The patient was not taking concomitant medications. The patient was not pregnant at the time of vaccination. The vaccine was administered in other facility. The patient did not receive other vaccines in four weeks, or other medications in two weeks. On 15Mar2021, at 8:00 AM, the patient experienced fever, nausea, chills, and headache. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has not been tested for Covid-19 post vaccination.   No follow up attempts are possible. No further information is expected.
It was reported that a 33 year old male patient received a JE-VAX and a Hepatitis B vaccination on 08/16/00. Reportedly 4 days after the vaccination 08/20/00, the patient developed itchy, red, and puffy rash over her entire body. She had fatigue, mild dizziness, nausea, swelling of her eyes, lower lips, hands, and joint pain. From additional correspondence received on 10/12/00, it was reported that the patient recovered from this experience. Additional vaccine, patient and responsible physician info was also provided. No further info is expected, this case is closed.
extremely tired; chills; This is a spontaneous report from a contactable consumer (patient). An elderly female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL9262) via an unspecified route of administration, administered on the right arm on 08Feb2021 12:00 at a single dose for COVID-19 immunisation. The patient had no medical history. There were no concomitant medications. The patient was vaccinated at 12 noon and felt fine thru Tues. On 10Feb2021 1:00 PM , the patient felt extremely tired and had the chills. Lasted thru the night and on Thurs. am all gone. No treatment was received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the events was recovered on 11Feb2021.
Information has been received from a medical assistant concerning a 12 month old female who on 09-Nov-2007 was vaccinated subcutaneously with a single dose of zoster vaccine live (Oka/Merck) (lot # not provided) instead of a dose of varicella virus vaccine live. The medical assistant confirmed that this was not product confusion. No problems were reported. The patient's status was not reported. No product quality complaint was involved. Additional information has been requested.
Stiff achy body and joints Fever and chills  Alternating Tylenol and ibuprofen and drinking plenty of liquids
This case was reported by a nurse via call center representative and described the occurrence of back pain in a 72-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included cyst removal (had surgery in July 2017 to remove the cysts and it was successful). In June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, 28 days after receiving SHINGRIX, the patient experienced back pain, cyst and fever. On an unknown date, the outcome of the back pain, cyst and fever were unknown. It was unknown if the reporter considered the back pain, cyst and fever to be related to SHINGRIX. Additional details were provided as follows: The patient did mention that she was going on a mission trip back in December 2017 and had to take a lot of vaccines and medications beforehand. The patient mentioned hepatitis, malaria and typhoid. The patient had to spend one week in the surgical unit and was transferred to rehabilitation for two weeks. The patient was unsure if those vaccines and medications have anything to do with her condition. Four weeks after receiving the 1st dose of SHINGRIX, the patient started to experience the back ache and fever and the back ache was causing excruciating pain. She went to the emergency room for treatment and she was sent home only to go back to the hospital two days later because of the pain. After running tests, it was noticed that she had developed three cysts on her spine which might be sitting on nerves. The patient was unsure if the vaccine was the cause but now she is looking into finding out if that was a possibility.
Systemic: Fainting / Unresponsive-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Seizure-Mild, Systemic: Weakness-Mild
no adverse reaction was reported. No other AE information reported; believes that it was injected into the muscle; This spontaneous report was received from a female patient of unknown age reporting on herself.The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.   On approximately on April 2019 (reported as about one month ago), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), 0.5 ml, 1 dose, subcutaneous, for prophylaxis(dosage schedule, anatomical location, lot number and expiration date were not reported).       On the same day, the patient believed that she was injected into the muscle (inappropriate route of vaccination).   The outcome of incorrect route of product administration and no adverse event is unknown.  No adverse reaction was reported.
Hives on right arm/hand on day 5 (Saturday), GI irritation from Sunday evening (day 6), and continuing. Eating white bread and banana only.  Fatigue, headache since Sunday (day 6). Medicating with Imodium & Tylenol.
first vaccine (Moderna) was injected on 02/03/2021, second vaccine (pfizer) was injected on 03/02/2021, my Mother was dead on 03/08/2021. with no symptoms on 03/07/2021.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose of VARIVAX, dose route and frequency unknown. On 15-MAY-2013, the patient was vaccinated with improperly stored VARIVAX dose 2, lot#:0610AE. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Pt admitted to hospital on 2/15/22 for Enterocutaneous fistula Intra-abdominal abscess Severe protein malnutrition Paroxysmal atrial fibrillation Chronic orthostatic hypotension End-stage renal disease Secondary adrenal insufficiency  2/17 Blood/plt tranfusion 2/27 GI bleeding 3/1  CT abd- no active bleeding, persistent air/fluid collection 3/28 fevers/sepsis 4/2 Unable to tolerated HD  4/8 Updated family regarding poor prognosis, offered hospice, asked to continue dialysis as long as possible 4/15 Death
- ?Moderna Covid-19 vaccine EUA? - 1/29/2021 @ 3 pm: received first dose of Moderna Covid-19 vaccine in the deltoid region of left arm (she did not receive a second dose because of the adverse reaction to the first dose of the vaccine) - First 3 days after the vaccine: normal local pain - On Monday morning February 1st 2021: left arm became highly sensitive to touch with tingling and sense of severe fatigue and weakness, At night, pins and needles and muscle twitches. This continued with variable intensity. - Friday February 5th : Started to feel Left leg strain as if pulled muscle, and at night twitches and prickling sensation in left lower limb - Saturday February 6th at night: right lower limb started to feel muscle strain and numbness - Sunday morning February 7th, we went to ER, the ER physician consulted the neurologist who ordered blood test for anti GM1 antibodies and scheduled a neurology consultation - Thursday February 12: neurology consultation (Video) with Dr., who advised to watch progress till the end of the month of February - Left arm started to feel muscle strain and numbness too - Muscle twitches continued in the 4 limbs with apparent weakness that affect her daily activities - Tuesday March 2nd Talked to the neurologist again, who recommended some blood tests and MRI of the neck - As of today March 3rd , still feeling weak arms and legs with muscle twitching specially at night, no problem with sensation. She became very emotional with high anxiety level
Case Completed primary Moderna vaccine series in February 2021, then was hospitalized for Covid and subsequently died in September 2021.  Hospitalized at Hospital. Discharging physician: MD  85 y/o fully vaccinated female presented with acute hypoxic resp failure from covid-19 pneumonia. Due to severity of illness and goals of care, she was started on comfort care and a morphine drip. The following am she passed away comfortably with family at bedside. Time of death was 11:35.
Narrative:  COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/19, Pfizer, dose #2 10/14, Pfizer, dose #3 12/22 COVID swab, result: detected 12/22 SARS-COV-2 Variant Sequencing: pending 12/21 pt cc: chills, sore throat, rhinorrhea, dyspnea, congestion & sneezing exposure wife 12/28 clinically resolved
Patient seen by a M.D. was told symptoms such as swelling of her gland, pain, dizziness, h/a, n/v where associated with receiving MMR vaccine.
- mild muscle burning/pinching sensations in the left arm, left trapezius, and left shoulder blade   - mild pain at the injection site(feels like bruising)
Woke in middle of night with chills fever and severe body aches that lasted until 2100 on 12/29/2020. Arm at injections site red swollen, hot to touch and itchy.
starting having pain & swelling @ inject @ 5PM day of inject 12JAN93, fever, chills constant pain @ inject site @ 11PM that noc; went to ER 14JAN93 due to sx;
Concomitant products included LEVOTHYROXINE SODIUM (L-THYROXIN 1A PHARMA) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE NODULE (bumpy on left arm), DISCOMFORT (Discomfort of left arm like arthritis), VACCINATION SITE PRURITUS (itchy on left arm), VACCINATION SITE ERYTHEMA (Redness on left arm) and VACCINATION SITE SWELLING (Swollen on left arm). At the time of the report, VACCINATION SITE NODULE (bumpy on left arm), DISCOMFORT (Discomfort of left arm like arthritis), VACCINATION SITE PRURITUS (itchy on left arm), VACCINATION SITE ERYTHEMA (Redness on left arm) and VACCINATION SITE SWELLING (Swollen on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other relevant concomitant medications included an unspecified blood pressure medicine and statin.  The patient did not take any treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Additional information was received on 10-May-2021 and contains no new information.
Loss of muscles below shoulders. Severe diarrhea. Unable to move limbs, thighs, legs, arms. could move only by pushing for ward by elbow  Severe dehydration, fever over 101F. Same day I was admitted to Emergency room. Discharged soon after. Then the same day a few hours later I lost muscle usage again and was admitted to Emergency room hospital. released about 4 hours later  This is the second time with the exact same reactions. The first time was on 02/26/2021 after my second Moderna vaccine 24 hours before.. I went to emergency room and was admitted to hospital for 2 nights. Emergency room and hospital.
Extreme Heart rate Resulting from (Myocarditis) from COVID 19 "Vaccine" Ongoing at rate of about 130-135 Beat Per Minute Day and Night (Resting or Other). This put me in hospital twice, cardiologist prescribing Blood Pressure Lowering meds Wrong for what was going on which cased me to CODE!
Patient had already received 2 doses of Pfizer from a different provider prior to this Moderna dose.
The pt experienced inconsolability, refusal to drink for 48 hours. Required admission to the hospital for 1 day for hydration.
lethargy; Flu like symptoms the night of my second dose; muscle aches; chills; low grade fever the next day; This is a spontaneous report from a contactable Consumer or other non-HCP (Patient reported for self). A patient of an unspecified age and gender received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0186), via an unspecified route of administration, in left arm on 06Jul2021, as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included anxiety, temporary schizophrenic symptoms and Allergies: Penicillin and the scent of cinnamon if large amounts. The concomitant medication of the patient was none. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: Unknown), via an unspecified route of administration, on an unspecified date, as a dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient was not tested for COVID post vaccination. On 06Jul2021, the patient experienced flu like symptoms, muscle aches, chills and low-grade fever. On 07Jul2021 (on the next day), the patient experienced lethargy. The patient received no treatment for the reported events. The outcome for all the reported events was resolved on an unspecified date in Jul2021.  Follow-up attempts are completed. No further information is expected.
Systemic: SOB, difficulty breathing, chest pain, Error: Wrong Patient (documentation in EMR); symptoms lasted 0 days
A 60-day follow up report received 8/4/2003 adds: Child had strep pneumonial meningitis, has seizure disorder and severe developmental delays. I do not feel that the vaccine caused the adverse event-the child contracted the meningitis, coincidentally, 2 days after her shots. Annual follow up on 11/21/2003: "Vaccine recipient did not recover from the adverse events that were reported for this vaccination.  I have reported this previoiusly.  As stated, this child has seizures, developmental delays, neurological impairments as a consequence of strep pneumoniae meningitis which she suffered within 3 days of her vaccination.  All her deficiencies are a result of step pneumoniae meningitis which she developed within 3 days of her vaccines-vaccines are not believe to have caused the meningitis."  Nurse follow up on 06/29/04 states: "ADD: Streptococcus pneumoniae, meningitis, seizure disorder, hearing loss, right eye deviation, febrile illness."
BODY ACHES; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included auto-immune issue.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022) .5 ml, once a total administered  on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced body aches. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced chills. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and chills on 07-MAR-2021, was recovering from body aches, and had not recovered from headache. This report was non-serious.
I felt extremely weak, then I started feeling sickly. I was cold and shivering and lost appetite that day. Also, my mouth was tasteless. I took paracetamol tablet after some time because I thought my body will fight the symptoms initially. After taking the paracetamol tablet, I slept for a while then I became okay. I started sweating and I was able to eat.
Soreness at the injection site; and a "splotchy" Rash on her torso; Malaise or "not feeling well"; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included allergic reaction to drug (allergic to NSAIDS).   In September 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site pain, rash and malaise. On an unknown date, the outcome of the injection site pain, rash and malaise were unknown.   It was unknown if the reporter considered the injection site pain, rash and malaise to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received first Shingrix vaccine approximately one week before time of reporting. The patient reported soreness at the injection site, Malaise or not feeling well, and a splotchy rash on her torso.  She stated that she was allergic to NSAIDS, and she had the exact same rash if she took an NSAIDS. The reporter did not consent to follow up.
soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (soreness). At the time of the report, INJECTION SITE PAIN (soreness) outcome was unknown.            No treatment information was reported. No relevant concomitant medications were reported.
Information has been received regarding a case in litigation from a lawyer and refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies were not reported. On 18-OCT-2007, the patient was vaccinated with ZOSTAVAX, (strength, route, anatomical location, dose, frequency, dose number, lot number and expiration date were not reported), for the permanent prevention and protection against shingles and zoster-related conditions/injuries. No other suspect or concomitant therapies were reported. On an unknown date, the patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering, extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of latent conditions, lost wages, loss of earning capacity and other losses and damages. On 07-FEB-2008, the patient was treated for herpes zoster. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter determined adverse events as medically significant, disabling and life-threatening events.
have primary Sjogrens; had a mild flare in my joints; my eyes became very gritty; Mild bronchospasm; Slightly sob on exertion; Mild seasonal asthma; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot ER8734, first dose) solution for injection intramuscular in the left arm on 29Mar2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included Sjogrens, mild seasonal asthma, CRPS (complex regional pain syndrome), and allergies to oranges and tomatoes. Concomitant medications included pregabalin (LYRICA), baclofen, levothyroxine, and prednisone. Past drug history included known allergy: SSRI's and codeine and all derivatives. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient stated, "I have primary Sjogrens, and mild seasonal asthma and within 3 hours of injection, I had a mild flair in my joints and my eyes became very gritty. I also had mild bronchospasm that responded to use of albuterol inhaler. I have not had to use inhaler in 2 years prior to this, and I had not had a joint flair in 2 years. These symptoms lasted about 72 hours. I needed to use inhaler several times, I was slightly SOB (shortness of breath) on exertion" on 29Mar2021 at 13:00. Treatment for the events included albuterol inhaler and increased prednisone (by the patient). The outcome of the events was recovered in Apr2021. Since the vaccination, the patient has not been tested for COVID-19.
Lot # GJ3277 Expiration# 12/12/22   He had his fifth COVID booster administered 2 days ago.  After that he had nausea, vomiting, generalized weakness, malaise, fatigue, headache.